The Decmil acquisition fits Macmahon’s strategic direction, although the price is steep for a business that has underperformed for years. A turnaround is possible backed by Macmahon’s management and balance sheet, but we will need evidence to be convinced. We don’t need persuading on the rest of the business though, which is tracking well.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.